Ungerstedt U, Herrera-Marschitz M, Ståhle L, Tossman U, Zetterström T
Psychopharmacology Suppl. 1985;2:19-30. doi: 10.1007/978-3-642-70140-5_3.
A series of experiments is described in which behavioral models and intracerebral dialysis were used to study neurotransmitter release and which illustrate the functional properties of different dopamine receptors. Evidence is presented for the existence of postsynaptic D-1 dopamine receptors, which are preferentially stimulated by apomorphine and inhibited by SCH 23390, and postsynaptic D-2 receptors, which are preferentially stimulated by pergolide and inhibited by sulpiride. On the basis of results obtained following systemic and local treatment with picrotoxin it seems probable that D-2 receptors are located on GABA interneurons in the striatum. Furthermore, lesion studies indicate that the D-1 and D-2 receptors are related to different neuronal pathways. In contrast to postsynaptic dopamine receptors, presynaptic autoreceptors, as studied by recording the decrease in exploratory behavior and dopamine release, seem not to differ in their response to apomorphine and pergolide. Sulpiride selectively inhibits dopamine autoreceptors and is equally potent in inhibiting apomorphine and pergolide autoreceptor-dependent responses. In summary, the data strongly support the existence of functionally important D-1 and D-2 receptors.
本文描述了一系列实验,这些实验使用行为模型和脑内透析来研究神经递质释放,并阐明不同多巴胺受体的功能特性。文中提供了证据,证明存在优先受阿扑吗啡刺激且受SCH 23390抑制的突触后D-1多巴胺受体,以及优先受培高利特刺激且受舒必利抑制的突触后D-2受体。基于用印防己毒素进行全身和局部治疗后获得的结果,D-2受体似乎很可能位于纹状体的GABA中间神经元上。此外,损伤研究表明D-1和D-2受体与不同的神经通路有关。与突触后多巴胺受体相反,通过记录探索行为和多巴胺释放的减少来研究的突触前自身受体,对阿扑吗啡和培高利特的反应似乎没有差异。舒必利选择性抑制多巴胺自身受体,在抑制阿扑吗啡和培高利特自身受体依赖性反应方面同样有效。总之,这些数据有力地支持了功能上重要的D-1和D-2受体的存在。